Born in Eindhoven, Autoscriber is aiming to create a positive impact in healthcare through tech. The startup, which was a finalist in last year’s EU-Startups Pitch Competition, has just secured fresh funding as demand for innovative healthtech solutions grows.
Healthcare is a fundamental part of everyday life. Across the world, though, healthcare systems are under pressure. Compounded with systemic issues and the aftermath of a global pandemic, healthcare systems are dealing with surmounting challenges – and it’s the growing vertical of healthtech that might be able to resolve the problems.
There’s currently a declining number of medical pressures as stress and pressure escalate. Together with ageing populations and the need to digitize processes and recordkeeping, this puts an enormous load on doctors, nurses and other healthcare workers all over the world. This is what Autoscriber aims to tackle and the startup has just secured new funding.
Jacqueline Kazmaier, co-founder of Autoscriber: “Our goal is to bring the human-centric element of medical consultations back to the forefront and to make tedious administrative tasks a thing of the past.”
- €1.2 million raised in a seed round from LUMO Labs and the Brabant Development Agency (BOM)
- Autoscriber has been a LUMO Labs portfolio company since 2021
- The funding will be used to grow the Autoscriber team and scale tech development.
Sven Bakkes, LUMO Labs Founding PartnerSven Bakkes, LUMO Labs Founding Partner: “Through our Venture Builder Program, we continuously challenge our founders in many different ways. Jacqueline and Koen have brought together an exceptional team capable of turning a big vision into action. We look forward to our continued collaboration with them and their expanding team.”
Founded in 2021, Autoscriber envisions a world where doctors can truly focus on patients by relieving them of their administrative burden. As healthcare systems struggle under pressure, there is potential in making healthcare more data-driven and automated. The challenge is that data-driven approaches to patient care (e.g. diagnostic support, analytics, precision medicine) require a lot of data on the patient and thus very complete patient files or Electronic Health Records (EHRs).
Koen Bonenkamp, co-Founder of Autoscriber: “In practice, we see that medical practitioners don’t have the time to fill out EHRs the way they are designed. Many valuable insights to improve healthcare get lost because data is captured in a suboptimal format or not captured at all.”
Autoscriber uses AI-powered speech recognition tech to extract structured clinical data from conversations between patients and physicians and acts as a digital scribe for the doctor. The Autoscriber “Flow” product allows medical practitioners to record the conversation using their mobile phones and to receive real-time suggestions to fill out the EHR. The solution saves time, captures more data and improves the consultation experience for doctor and patient, as there is more room for human connection.
Andy Lürling, LUMO Labs Founding Partner: “Autoscriber’s ever-increasing traction in healthcare clearly shows the market potential of their proposition. The additional funding will be used to speed up the roll-out and further development of the software and so increase its impact.”
Now, with this funding, the healthtech innovators plan to grow the team and expand product development. We’re excited to see what’s to come from this team and will be keeping a close eye. They certainly caught our attention at last year’s Pitch Competition – and it makes us even more excited about this year’s event!
Jaqueline Kazmaier: “Our pre-seed phase was our ‘build & learn phase’; this investment will fund our ‘validate & optimize phase’ and in the following round we will focus on scale. We have reached the point where we have proven that the problem is real and that what we are building can offer a solution. There is clearly a huge need in the market and a willingness to make radical change – we struggle to keep up with requests for collaborations.”
Koen Bonenkamp: “To meet this demand, Autoscriber will use the new capital to grow the team. Our home base at the High Tech Campus and our development office in Cape Town give us access to a global talent pool. We’ll not only add more technical brainpower, but we’ve also made some exceptional operations and commercial hires in order to be ready for this exciting next phase.”
The 2023 edition of the EU-Startups Summit will take place in Barcelona on April 20-21, providing two days of networking, inspiration and learning. It’s an exciting opportunity to connect with Europe’s most influential founders, investors and innovators, and meet fellow startup enthusiasts. We’ll once again host a Pitch Competition to spotlight promising early-stage startups, like Autoscriber – applications are now open!
Want to join us? Secure your ticket for the Summit here today!
Robin Hendrickx, BOM Investment Manager: “We are thrilled to support this talented team in building an AI-first product to fundamentally improve healthcare workflows. By leveraging data and AI, Autoscriber can meaningfully reduce doctors’ admin workload and, as a result, improve doctor satisfaction and patient outcomes.”